LYMPHANGIOMA

Clinical trials for LYMPHANGIOMA explained in plain language.

Never miss a new study

Get alerted when new LYMPHANGIOMA trials appear

Sign up with your email to follow new studies for LYMPHANGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for rare blood vessel disorders: targeted drugs enter trial

Disease control Recruiting now

This study tests two targeted drugs (alpelisib and mirdametinib) in 50 people aged 2 and older with vascular malformations—abnormal blood or lymph vessels. Participants receive 48 weeks of treatment based on their genetic mutation type. The goal is to see if these drugs improve e…

Matched conditions: LYMPHANGIOMA

Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control

Last updated May 17, 2026 06:52 UTC

LYMPHANGIOMA

Get alerted when new LYMPHANGIOMA trials appear

New hope for rare blood vessel disorders: targeted drugs enter trial